ASP
FUSN

Adams Street Partners’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Adams Street Partners’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,947,809
Closed -$28.3M – 18
2023
Q4 		$28.3M Hold
2,947,809
– – 8.73% 5
2023
Q3 		$7.66M Hold
2,947,809
– – 2.68% 8
2023
Q2 		$13.8M Hold
2,947,809
– – 3.6% 6
2023
Q1 		$11.1M Hold
2,947,809
– – 3.47% 7
2022
Q4 		$9.29M Hold
2,947,809
– – 3.1% 6
2022
Q3 		$8.87M Hold
2,947,809
– – 2.43% 6
2022
Q2 		$7.34M Hold
2,947,809
– – 1.91% 7
2022
Q1 		$22.9M Hold
2,947,809
– – 4.24% 7
2021
Q4 		$12.3M Hold
2,947,809
– – 1.88% 8
2021
Q3 		$23.3M Sell
2,947,809
-25,935
-0.9% -$218K 3% 7
2021
Q2 		$24M Sell
2,973,744
-15,900
-0.5% -$137K 4.99% 4
2021
Q1 		$32M Sell
2,989,644
-503,105
-14% -$5.88M 5.14% 5
2020
Q4 		$41M Sell
3,492,749
-9,676
-0.3% -$122K 8.53% 4
2020
Q3 		$40M Hold
3,502,425
– – 10.54% 4
2020
Q2 		$55.1M Buy
+3,502,425
New +$61M 11.39% 4

Other funds holding FUSN

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adams Street Partners's FUSN Position: Q1 2024 in Review

Adams Street Partners sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q1 2024, closing a stake of 2,947,809 shares — an estimated $28.3M sold.

Adams Street Partners first reported a position in FUSN in Q2 2020 and held it in 15 quarters. The position peaked at $55.1M in Q2 2020. 114 funds tracked by Wall St. Rank hold FUSN as of Q1 2024.

  • Adams Street Partners reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q1 2024 after selling out during the quarter.
  • Adams Street Partners sold 2,947,809 Fusion Pharmaceuticals Inc. Common Shares shares in Q1 2024, an estimated $28.3M.
  • Adams Street Partners first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and held it in 15 quarters.
  • Adams Street Partners's Fusion Pharmaceuticals Inc. Common Shares position peaked at $55.1M in Q2 2020.
  • 114 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q1 2024.

Based on Adams Street Partners's 13F filing for Q1 2024, filed 14 May 2024.